Application

18573359 · NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE 2A, 2B or 2C AGONISTS

Filed 2023-12-21 · Pending The official file ↗ · Art unit 1624 · Examiner Rilla Marie Samsell Typical · CPC A61K 31/485 · LDN Pharma Limited · Joseph R. Baker, APC

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

26.6 mo

to disposition n/a

Statutes raised

102 103 112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.